Dr. med. Daniel Schondube
internal medicine, hematology, oncology, and palliative medicine
internal medicine, hematology, oncology, and palliative medicine
Overview
Country, City
Germany, Bad Saarow
Health facility
Helios Hospital Bad Saarow
Medical unit
Department of hematology
About the doctor
Skills & Expertise
hematology
internal medicine
leukemia
oncology
myeloid
myeloid leukemia
palliative medicine
neoplasia
hematological neoplasia
promyelocytic leukemia
fludarabine
cebpa
npm1
factor npm1 mutated
monoallelic cebpa mutations
karyotype
cytarabine
cancer
sarscov2
influenza
mutations
head
chemotherapy
Resume
CV (Curriculum Vitae)
Education
- 1994-2001 Studied human medicine at the Free University and Humboldt University in Berlin
- 2003 Obtaining a license for medical practice
- 2009 Defense of the doctorate
- 2002-2009 Resident of the Department of hematology at the Helios Hospital Berlin Buch
- 2009 Obtaining specialization in internal medicine
- 2011 Obtaining specialization in palliative medicine
- 2016 Received additional qualifications in the field of internal medicine, hematology, and oncology
- 2016 Master’s degree in business administration at the Berlin University of Economics and Law
Experience
- 1992-1993 Civilian service as a paramedic at the rescue service of the district Ploen
- 2009-2014 Senior Physician of the Department of hematology at the Helios Hospital Berlin Buch
- 2014 Senior Physician of the Department of hematology at the Helios Hospital Bad Saarow
- 2019 Head of the Department of hematology at the Helios Hospital Bad Saarow
- 2022 Chief Physician of the Department of hematology at the Helios Hospital Bad Saarow
- Department of hematological neoplasia at the Helios Hospital Bad Saarow
Awards & Memberships
- Member of the German Society for Hematology and Oncology
- Member of the German Society for Internal Medicine
- Member of the European Hematology Association
Languages
English
German
Publications
Mortality in cancer patients with SARS-CoV-2 or seasonal influenza: an observational cohort study from a German-wide hospital network.
February, 2023
Impact of Age and Midostaurin-Dose on Response and Outcome in Acute Myeloid Leukemia with FLT3-ITD: Interim-Analyses of the AMLSG 16-10 Trial
2 December, 2016
Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG.
May, 2014
Location
Pieskower Str., 33, 15526 Bad Saarow, Germany
FAQ
Where does the doctor practice?
What is the specialization of Dr. med. Daniel Schondube?
The primary specialization of the doctor is internal medicine, hematology, oncology, and palliative medicine.
What is the experience of the specialist?
Dr. med. Daniel Schondube has been practicing for more than 23 years.
Dr. med. Daniel Schondube
Get individual treatment plan and cost estimate. Non-binding 100% free assessment.
© Dr. med. Daniel Schondube